Press Releases + News

Date	Title and Summary	View
Toggle SummaryOct 12, 2011	Galectin Therapeutics Elects Dr. Marc Rubin to its Board of Directors	View HTML Galectin Therapeutics Elects Dr. Marc Rubin to its Board of Directors 15.8 KB
Toggle SummaryOct 03, 2011	Galectin Therapeutics Board Member John Mauldin Plans to Purchase Stock Under 10b5-1 Plan; Company Featured in his e-newsletter "Thoughts from the Frontline"	View HTML Galectin Therapeutics Board Member John Mauldin Plans to Purchase Stock Under 10b5-1 Plan; Company Featured in his e-newsletter "Thoughts from the Frontline" 15.6 KB
Toggle SummarySep 29, 2011	Galectin Therapeutics Posts New Corporate Presentation Video to its Website Highlights Leadership Position Developing Galectin-Inhibiting Therapeutics to Treat Fibrosis & Cancer	View HTML Galectin Therapeutics Posts New Corporate Presentation Video to its Website 16.1 KB
Toggle SummarySep 07, 2011	Galectin Therapeutics to Present Corporate Update at the Rodman & Renshaw HealthcareConference	View HTML Galectin Therapeutics to Present Corporate Update at the Rodman & Renshaw HealthcareConference 16.6 KB
Toggle SummaryAug 12, 2011	Galectin Therapeutics Reports Financial Results for Second Quarter 2011	View HTML Galectin Therapeutics Reports Financial Results for Second Quarter 2011 18.1 KB
Toggle SummaryAug 05, 2011	10X Fund Issues Statement Regarding Investment in Galectin Therapeutics	View HTML 10X Fund Issues Statement Regarding Investment in Galectin Therapeutics 18.2 KB
Toggle SummaryJul 21, 2011	Galectin Therapeutics Announces Research Collaboration with Dr. Jose Jalife of the University of Michigan Medical School to Explore Role of Galectins in Cardiovascular Disease	View HTML Galectin Therapeutics Announces Research Collaboration with Dr. Jose Jalife of the University of Michigan Medical School to Explore Role of Galectins in Cardiovascular Disease 16.7 KB
Toggle SummaryJun 15, 2011	ADDING and REPLACING Galectin Therapeutics Announces New Stock Trading Symbol "GALT"	View HTML ADDING and REPLACING Galectin Therapeutics Announces New Stock Trading Symbol "GALT" 13.4 KB
Toggle SummaryJun 14, 2011	Galectin Therapeutics Expands European Patent Coverage Patent Covers Use of GM-CT-01 with Chemotherapy to Increase Effectiveness and Reduce Side Effects of Cancer Treatments	View HTML Galectin Therapeutics Expands European Patent Coverage 18.4 KB
Toggle SummaryJun 09, 2011	Galectin Therapeutics to Present Corporate Update at NIBA Conference	View HTML Galectin Therapeutics to Present Corporate Update at NIBA Conference 16 KB